GCP
GPCR icon

GSA Capital Partners’s Structure Therapeutics GPCR Stock Holding History

GSA Capital Partners’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.54M Buy
28,665
+14,854
+108% +$657K 0.1% 268
2026
Q1 		$666K Buy
+13,811
New +$945K 0.04% 739
2025
Q4 		– Sell
-9,886
Closed -$277K – 1822
2025
Q3 		$277K Buy
+9,886
New +$197K 0.02% 1247
2024
Q4 		– Sell
-30,464
Closed -$1.34M – 1755
2024
Q3 		$1.34M Buy
+30,464
New +$1.18M 0.1% 297

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

GSA Capital Partners's GPCR Position: Q2 2026 in Review

GSA Capital Partners increased its Structure Therapeutics (GPCR) stake by 108% in Q2 2026, buying an estimated $657K and bringing the position to 28,665 shares worth $1.54M. The position accounts for 0.1% of the portfolio, ranked #268.

GSA Capital Partners first reported a position in GPCR in Q3 2024 and has held it in 4 quarters since. 191 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • GSA Capital Partners held 28,665 shares of Structure Therapeutics worth $1.54M as of Q2 2026.
  • GSA Capital Partners bought 14,854 Structure Therapeutics shares in Q2 2026, an estimated $657K.
  • Structure Therapeutics made up 0.1% of GSA Capital Partners's portfolio in Q2 2026, its #268 holding.
  • GSA Capital Partners first reported a position in Structure Therapeutics in Q3 2024 and has held it in 4 quarters since.
  • 191 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.